Description
An orexin 1 and orexin 2 receptor antagonist (Kis = 4.7 and 0.9 nM, respectively); decreases the latency to persistent NREM and REM sleep and increases the duration of NREM and REM sleep in male rats when administered at a dose of 100 mg/kg; does not impair spatial learning and memory in the Morris water maze at 300 mg/kg
Formal name: (αR,1S)-3,4-dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide, monohydrochloride
Synonyms: ACT 078573
Molecular weight: 549
CAS: 913358-93-7
Purity: ≥98%
Formulation: A crystalline solid
Application|Mass Spectrometry||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Behavioral Neuroscience|Sleep & Biological Rhythms